CytomX Therapeutics
CTMX
CTMX
68 hedge funds and large institutions have $185M invested in CytomX Therapeutics in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $308M → $185M (-$123M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
68
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$10.2M | |
| 2 | +$2.21M | |
| 3 | +$1M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1M |
| 5 |
Morgan Stanley
New York
|
+$649K |
Top Sellers
| 1 | -$3.52M | |
| 2 | -$407K | |
| 3 | -$261K | |
| 4 |
Neuberger Berman Group
New York
|
-$224K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$211K |